Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Memorandum number 202317020
Slowly but surely, the scale kept moving, and after 11 months, I reached my weight loss goal and gained even more muscle
Quick Takeaways Retatrutide is a triple-receptor agonist (GLP-1, GIP, glucagon) delivering superior monotherapy weight loss at 2428.7% over 4868 weeks Cagrilintide targets amylin receptors for satiety and gastric emptying, achieving 10.8% weight loss in 26 weeks as a monotherapy Retatrutide provides broader metabolic benefits, including dramatic improvements in HbA1c, blood pressure, waist circumference, insulin sensitivity, and liver fat normalization No head-to-head trials exist yet, but the mechanistic and clinical data strongly favor Retatrutide for total body recomposition Retatrutide vs Cagrilintide: Side-by-Side Comparison What Makes Retatrutide Different Retatrutide isnt just another GLP-1 receptor agonist
In their recent study, Cardia et al
In studies with rodents, Ozempic and medicines that work like Ozempic caused thyroid tumors, including thyroid cancer
US$ 20.77
US$ 27.82
US$ 25.86
US$ 20.29
US$ 23.39
US$ 21.06
US$ 23.01
US$ 27.16
US$ 28.44
US$ 29.62
US$ 24.73
US$ 29.48
US$ 29.73
US$ 29.12
US$ 21.88
US$ 26.28
